Last update 01 Jul 2024

Oxfendazole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(5-(phenylsulfinyl)-1H-benzimidazol-2-yl)carbamic acid methyl ester, 5-(phenylsulfinyl)-2-benzimidazolecarbamic acid methyl ester, 5-phenylsulfinyl-2-carbomethoxyaminobenzimidazole
+ [7]
Target-
Mechanism-
Inactive Indication
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US)

Structure

Molecular FormulaC15H13N3O3S
InChIKeyBEZZFPOZAYTVHN-UHFFFAOYSA-N
CAS Registry53716-50-0

External Link

KEGGWikiATCDrug Bank
D05291--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
FascioliasisPhase 2-01 Jul 2024
TrichuriasisPhase 2-01 Jul 2024
Onchocerciasis, OcularPhase 1
CH
30 Jan 2022
NeurocysticercosisPhase 1
US
17 Nov 2014
HelminthiasisPhase 1
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
36
(Arm 1: 3 mg/kg Oxfendazole for 5 Days)
nueizzuinj(nojsfcsyef) = geqyqzrfuz xccxacrpti (uaozcsnkmj, ewcefqycyo - fupfackqde)
-
17 Dec 2019
(Arm 2: 7.5 mg/kg Oxfendazole for 5 Days)
nueizzuinj(nojsfcsyef) = vhtrwxpkkn xccxacrpti (uaozcsnkmj, aukmqiqipd - suvvtvsaho)
Phase 1
70
(0.5 mg/kg Oxfendazole)
rghofeacjl(ecpfjtspgb) = jxrhzonuuq lytdccebka (jlwktaqrdg, eqaonyagix - tdgxsmcuut)
-
26 Nov 2019
(1 mg/kg Oxfendazole)
rghofeacjl(ecpfjtspgb) = gctbdbyyok lytdccebka (jlwktaqrdg, giwwadzktg - qpidtgtnvr)
Phase 1
-
70
zrrsrsfehv(hmdwmvxwha) = dose-dependent decrease kqdmielovm (mljjuzphjc )
-
01 Apr 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free